From the purpose of treatment, breast cancer can be divided into three subtypes: human epidermal growth factor receptor 2 (HER2) positive, androgen and progesterone receptor (ER, PR) positive, and triple-negative (Weigelt and Reis-Filho, 2009). Here, PGR is linked to breast carcinoma.